Search research articles
Contact Us
Filters
Showing results (381-390 of 508) with videos related to
Page
of 51
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 21, 2013
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine
Kimberly Y Smith, Camlin Tierney, Katie Mollan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 23, 2017
Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis
Alexander J Stockdale, Matthew J Saunders, Mark A Boyd, et al.
Bioresearch Open Access
|
February 11, 2016
A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons Learned
Ann C Collier, Tae-Wook Chun, Janine Maenza, et al.
AIDS (London, England)
|
August 16, 2001
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression
D V Havlir, P B Gilbert, K Bennett, et al.
AIDS (London, England)
|
September 24, 2016
Long-term body composition changes in antiretroviral-treated HIV-infected individuals
Philip M Grant, Douglas Kitch, Grace A McComsey, et al.
Archives of Neurology
|
January 16, 2008
Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system
Scott Letendre, Jennifer Marquie-Beck, Edmund Capparelli, et al.
International Journal of STD & AIDS
|
August 24, 2013
Neurocognitive impairment in HIV-infected individuals with previous syphilis
C M Marra, R Deutsch, A C Collier, et al.
Plos One
|
June 7, 2013
Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design
Pratima Kunwar, Natalie Hawkins, Warren L Dinges, et al.
The Journal of Infectious Diseases
|
February 22, 2001
Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy
A Seth, J Markee, A Hoering, et al.
AIDS (London, England)
|
February 9, 2012
Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration
David Croteau, Brookie M Best, Scott Letendre, et al.
Page
of 51
Search research articles
Search
Showing results (381-390 of 508) with videos related to
Sort By:
Page
of 51
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 21, 2013
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine
Kimberly Y Smith, Camlin Tierney, Katie Mollan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 23, 2017
Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis
Alexander J Stockdale, Matthew J Saunders, Mark A Boyd, et al.
Bioresearch Open Access
|
February 11, 2016
A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons Learned
Ann C Collier, Tae-Wook Chun, Janine Maenza, et al.
AIDS (London, England)
|
August 16, 2001
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression
D V Havlir, P B Gilbert, K Bennett, et al.
AIDS (London, England)
|
September 24, 2016
Long-term body composition changes in antiretroviral-treated HIV-infected individuals
Philip M Grant, Douglas Kitch, Grace A McComsey, et al.
Archives of Neurology
|
January 16, 2008
Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system
Scott Letendre, Jennifer Marquie-Beck, Edmund Capparelli, et al.
International Journal of STD & AIDS
|
August 24, 2013
Neurocognitive impairment in HIV-infected individuals with previous syphilis
C M Marra, R Deutsch, A C Collier, et al.
Plos One
|
June 7, 2013
Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design
Pratima Kunwar, Natalie Hawkins, Warren L Dinges, et al.
The Journal of Infectious Diseases
|
February 22, 2001
Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy
A Seth, J Markee, A Hoering, et al.
AIDS (London, England)
|
February 9, 2012
Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration
David Croteau, Brookie M Best, Scott Letendre, et al.
Page
of 51